Volume 10, 2023

HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!

New method of clustering colorectal cancer patients using differential presence of exons (DPE) sequencing

Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer development

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

Think outside the box – atypical infections in chronic sinusitis

Cancer cell repopulation after therapy: which is the mechanism?

Transforming early cancer detection in primary care: harnessing the power of machine learning

Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer

Kinase-targeted therapy in subsets of colorectal cancer

Adenoid cystic carcinoma of the head and neck – treatment strategies of a highly malignant tumor with variable localizations

Squamous cell carcinoma of the oral cavity – follow up treatment and distant metastatic behavior

Cancer drug development yesterday, today and tomorrow

Lipiodol: from intrusion until exile from the tumor microenvironment

Exiting the pandemic together: achieving global immunity and equity

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma